当前位置： SCI文献检索 > ANNALS OF SURGERY期刊下所有文献 > Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?

Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?

Abstract：

OBJECTIVE:To determine long-term survival after pancreatoduodenectomy for pancreatic ductal adenocarcinoma and to identify clinical factors associated with long-term survival. SUMMARY BACKGROUND DATA:The prognosis for long-term survival even after potentially curative resection for pancreatic adenocarcinoma is thought to be poor. Clinical factors determining short-term survival after pancreatic resection are well studied, but prognostic factors predicting long-term survival with a potential for cure are poorly understood. METHODS:A case-control study was conducted of 357 patients who underwent pancreatoduodenectomy for pancreatic ductal adenocarcinoma between 1981 and 2001. Histologic specimens were reanalyzed to confirm diagnosis. Follow-up was at least 5 years or until death. RESULTS:There was an improved survival throughout the observation period (P = 0.004). We found 62 actual 5-year survivors of whom 21 patients survived greater than 10 years, for a 5- and 10-year survival rate of 18% and 13%, respectively. Cohort analysis comparing patients with short-term (<5 years, n = 295) and long-term (> or =5 years, n = 62) survival showed that more advanced disease (greatest tumor diameter, lymph node metastasis) and decreased serum albumin concentration were unfavorable for long-term survival (all P < 0.05). In contrast, the extent of resection and more aggressive histologic features did not correlate with long-term survival (all P > 0.05). En-bloc resection (P = 0.005) but not resection margin status (P > 0.05) was associated with long-term survival. Adjuvant chemoradiation therapy did not significantly influence long-term survival. Multivariate analysis identified lymph node status (OR 0.36, 95% CI 0.14-0.89, P = 0.03) as a prognostic factor for long-term survival. Five-year survival was no guarantee of cure because 16% of this subset died of pancreatic cancer up to 7.8 years after operation. CONCLUSION:Pancreatoduodenectomy for adenocarcinoma in the head of pancreas can provide long-term survival in a subset of patients, particularly in the absence of lymph node metastasis. One of 8 patients can achieve 10-year survival with a potential for cure.

journal_name

Ann Surg

journal_title

Annals of surgery

authors

Schnelldorfer T,Ware AL,Sarr MG,Smyrk TC,Zhang L,Qin R,Gullerud RE,Donohue JH,Nagorney DM,Farnell MB

doi

10.1097/SLA.0b013e3181613142

subject

Has Abstract

pub_date

2008-03-01 00:00:00

pages

456-62

issue

eissn

0003-4932

issn

1528-1140

pii

00000658-200803000-00010

journal_volume

247

pub_type

杂志文章

在线工具

Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?